Screening and Diagnosing BK Virus

Because the BK virus (BKV) usually reactivates without causing any physical symptoms, your care team relies on a strict schedule of blood and urine tests to “catch” the virus before it can cause permanent damage to your new kidney ^[1]. Screening is the most important tool we have for protecting your transplant, and it follows a standardized timeline set by international medical experts ^[2].

Your Screening Schedule

Current guidelines from the AST Infectious Diseases Community of Practice and the 2024 International Consensus recommend a rigorous screening schedule to stay ahead of the virus ^[2][3]:

• Months 1 to 9: You should have a blood test (plasma PCR) once every month. This is the period of highest risk for viral reactivation.
• Months 10 to 24: Screening moves to once every 3 months.
• After 2 years: Routine screening schedules become individualized. Your team will base further testing on your prior history with BK virus, your kidney function, and whether your immunosuppression medications are ever increased.

Understanding the Tests: Urine vs. Blood

There are several ways to look for the virus, but they do not all carry the same weight when it comes to making treatment decisions.

• Urine Decoy Cells: In this test, a pathologist looks at your urine under a microscope for “decoy cells”—cells that look strange because they are infected with the virus ^[4]. While helpful, this test has limited sensitivity and is not specific for BK virus alone; similar findings can occur with other viruses. Therefore, decoy cells alone should not trigger immediate medication changes ^[5].
• Urine BK PCR: This measures the actual amount of virus in your urine (viruria). Because many patients have virus in their urine without it ever entering their blood or harming the kidney, a high urine count is considered an “early warning sign” rather than a definitive diagnosis ^[6].
• Plasma BK PCR: This is the gold standard for non-invasive monitoring ^[2]. It measures the amount of virus in your blood (viremia). This test is much more accurate at predicting which patients are at risk for kidney damage and is the primary tool used to make treatment decisions ^[7].

Critical Action Thresholds

Doctors use specific numbers (thresholds) from your blood tests as guideposts to decide when to take action. Because PCR assays and laboratories vary, these thresholds are approximate guides, and clinicians look at trends over time rather than a single number:

1. Probable Nephropathy: A viral load of more than 1,000 copies/mL that is sustained for more than two weeks ^[2].
2. Presumptive Nephropathy: A viral load that rises above 10,000 copies/mL ^[3].

When your blood levels reach these points, your doctor will likely begin a “preemptive” reduction in your anti-rejection medications to help your immune system fight the virus ^[2]. It is important to note that a positive urine test or the presence of decoy cells alone should not trigger these medication changes without a confirmatory blood test ^[8].

The Role of Creatinine

You may notice your doctor checking your serum creatinine—a blood marker of how well your kidney is filtering waste. If your creatinine levels rise, it is a sign that the kidney is struggling ^[9].

However, a rising creatinine level is non-specific. This means it can be caused by many things other than the BK virus, including organ rejection, medication toxicity, or dehydration ^[10][11]. If your creatinine rises while your BK viral load is also high, your doctor may recommend a biopsy—taking a tiny sample of kidney tissue—to see exactly what is happening inside the organ ^[12]. A biopsy remains the best method for definitive histologic confirmation of BK Virus Nephropathy (BKVN), although a biopsy can sometimes miss focal (patchy) disease ^[1].